🇺🇸 FDA
Patent

US 7494775

Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer

granted A61PA61P35/00

Quick answer

US patent 7494775 (Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer) held by UT Board of Regents expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UT Board of Regents
Grant date
Tue Feb 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P35/00